FDA Comissioner announces new task force to study the agency's transparency

New US Food and Drug Administration Commissioner Margaret Hamburg revealed at the start of this month that a task force has been  established to develop recommendations for enhancing the transparency  of the organization's operations and decision-making process, with the  aim of creating greater openness.

To support the efforts of the task force, the FDA issued a Federal  Register notice announcing a June 24 public meeting to solicit  recommendations on how the agency can make useful and understandable  information on its activities and decisions more available.

"Our administration is committed to making government open and  transparent," said Health and Human Services Secretary Kathleen  Sebelius, commenting in the FDA's press statement. "The Transparency  Task Force will give the American people a seat at the table and make  the FDA more open and accountable," she added.